Fariborz Kamal
Presidente en 4D MOLECULAR THERAPEUTICS, INC. .
Fortuna: 139 815 $ al 30/04/2024
Origen de la red de primer grado Fariborz Kamal.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
American University
77
| College/University | Other Consumer Services | 77 |
San Jose State University
56
| College/University | Other Consumer Services | 56 |
| Public Company | Biotechnology | 26 | |
22
| Extinct | Biotechnology | 22 |
| Subsidiary | Biotechnology | 21 | |
| Subsidiary | Biotechnology | 10 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Fariborz Kamal a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| CELGENE | Biotechnology | President Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Sales & Marketing Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Director/Board Member | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Public Communications Contact | |
| AMARIN CORPORATION PLC | Pharmaceuticals: Major | Director/Board Member Chairman | |
| BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Chief Executive Officer Chief Executive Officer General Counsel | |
Aerogen, Inc.
 Aerogen, Inc. Medical SpecialtiesHealth Technology Aerogen, Inc. develops and manufactures aerosol products for treatment of respiratory disorders in the critical care setting. Its products include Aerogen Solo, Aerogen Ultra, Aerogen Pro, Pro-C controller, and USB controller. The company is headquartered in Deerfield, IL. | Medical Specialties | Chief Tech/Sci/R&D Officer Director/Board Member | |
Pharmasset, Inc.
 Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | Pharmaceuticals: Other | President Director/Board Member | |
| ALEXZA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
| ANTHERA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member | |
Elan Pharmaceuticals, LLC
 Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | General Counsel Chief Tech/Sci/R&D Officer | |
| INTERCEPT PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| HYPERION THERAPEUTICS INC | Pharmaceuticals: Major | Chairman Director/Board Member | |
SillaJen Biotherapeutics, Inc.
 SillaJen Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services SillaJen Biotherapeutics, Inc. develops and commercializes cancer therapeutics. It focuses on the development and commercialization of first-in-class, breakthrough targeted oncolytic immunotherapy products for solid tumors. It is focused on two main programs, lead product candidate, which is in mid-stage clinical development for the treatment of advanced primary liver cancer and colorectal cancer and JX-929 which is under investigation for a variety of other solid tumors. The company was founded by John C. Bell and David H. Kirn in 2006 and is headquartered in San Francisco, CA. | Miscellaneous Commercial Services | Founder Chief Tech/Sci/R&D Officer | |
| PRINCIPIA BIOPHARMA INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| ULTRAGENYX PHARMACEUTICAL INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Sofinnova Investments, Inc.
 Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor Private Equity Investor | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Corporate Officer/Principal | |
| Stanford University | College/University | Masters Business Admin President Undergraduate Degree | |
| University of Oxford | College/University | Corporate Officer/Principal Undergraduate Degree Graduate Degree | |
| George Mason University | College/University | Corporate Officer/Principal Graduate Degree | |
| New York University | College/University | Undergraduate Degree Masters Business Admin | |
| Princeton University | College/University | Undergraduate Degree Undergraduate Degree | |
| University of California, Berkeley | College/University | Undergraduate Degree Undergraduate Degree Corporate Officer/Principal Doctorate Degree Undergraduate Degree | |
| The University of Colorado | College/University | Undergraduate Degree Doctorate Degree | |
| University of Illinois | College/University | Doctorate Degree Undergraduate Degree | |
| The University of California, San Francisco | College/University | Doctorate Degree Doctorate Degree Corporate Officer/Principal Doctorate Degree Doctorate Degree | |
| Federal Reserve Bank of New York | General Government | Director/Board Member President | |
| University College London | College/University | Doctorate Degree Doctorate Degree | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| The University of North Carolina at Charlotte | College/University | Masters Business Admin Undergraduate Degree | |
| PROTHENA CORPORATION PLC | Biotechnology | Chairman Director/Board Member | |
| ADVERUM BIOTECHNOLOGIES, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
| Stanford University School of Medicine | College/University | Doctorate Degree Doctorate Degree | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
| Columbia Business School | College/University | Masters Business Admin Masters Business Admin | |
Levo Therapeutics, Inc.
 Levo Therapeutics, Inc. BiotechnologyHealth Technology Levo Therapeutics, Inc. operates as a pharmaceutical company. The company is headquartered in Glenview, IL. | Biotechnology | Chairman Director/Board Member Corporate Officer/Principal | |
| SANA BIOTECHNOLOGY, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Ignite Immunotherapy, Inc.
 Ignite Immunotherapy, Inc. BiotechnologyHealth Technology Part of Pfizer Inc., Ignite Immunotherapy, Inc. is a company that designs and develops oncolytic virus vaccines. The company is based in New York, NY. The company was founded by David Schaffer, Douglas Hanahan, David H. Kirn, Theresa Janke, Melissa Kotterman. The CEO is Monika A. Vnuk. | Biotechnology | Founder Founder Founder Founder | |
| TAYSHA GENE THERAPIES, INC. | Biotechnology | Director/Board Member Chief Executive Officer Director/Board Member Founder | |
Jaguar Gene Therapy LLC
 Jaguar Gene Therapy LLC Medical/Nursing ServicesHealth Services Jaguar Gene Therapy LLC is a company that aims to accelerate breakthroughs in gene therapy for patients suffering from severe genetic diseases. The company is based in Lake Forest, IL. The company's unrelenting commitment is to advocate boldly and care fiercely for patients and families. The company works together to confront the challenges of treating complex diseases and are advancing their initial pipeline that targets diseases with significant unmet need in sizeable patient populations. Joseph Nolan has been the CEO of the company since 2020. | Medical/Nursing Services | Director of Finance/CFO Chairman | |
| Escp Business School | College/University | Undergraduate Degree Undergraduate Degree | |
Berkeley Frontier Fund
 Berkeley Frontier Fund Investment ManagersFinance Berkeley Frontier Fund (Berkeley Frontier Fund) is a venture capital firm founded in 202. The firm is headquartered in Berkeley, California. | Investment Managers | Consultant / Advisor Private Equity Investor |
Estadísticas
Internacional
| Estados Unidos | 46 |
| Irlanda | 3 |
| Reino Unido | 3 |
| Francia | 2 |
Sectorial
| Health Technology | 27 |
| Consumer Services | 18 |
| Commercial Services | 3 |
| Finance | 3 |
| Electronic Technology | 2 |
Operativa
| Director/Board Member | 427 |
| Corporate Officer/Principal | 176 |
| Independent Dir/Board Member | 144 |
| Undergraduate Degree | 95 |
| Chairman | 89 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| James Healy | 50 |
| Thomas Daniel | 35 |
| David Kabakoff | 30 |
| Paul Manning | 26 |
| Carole Nüchterlein | 26 |
| William Jacobs | 24 |
| Daniel Welch | 24 |
| Marc Tessier-Lavigne | 24 |
| Shawn Tomasello | 22 |
| Lars Ekman | 21 |
| Jean-Jacques Bienaimé | 21 |
| Susannah Gray | 20 |
| Bill Burkoth | 19 |
| Jacob Chacko | 18 |
| Sean Nolan | 18 |
- Bolsa de valores
- Insiders
- Fariborz Kamal
- Conexiones Empresas